IBDEI1GN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24403,0)
 ;;=86580^^120^1218^11^^^^1
 ;;^UTILITY(U,$J,358.3,24403,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24403,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,24403,1,3,0)
 ;;=3^PPD Skin Test
 ;;^UTILITY(U,$J,358.3,24404,0)
 ;;=96372^^120^1218^15^^^^1
 ;;^UTILITY(U,$J,358.3,24404,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24404,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,24404,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,24405,0)
 ;;=90714^^120^1218^13^^^^1
 ;;^UTILITY(U,$J,358.3,24405,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24405,1,2,0)
 ;;=2^90714
 ;;^UTILITY(U,$J,358.3,24405,1,3,0)
 ;;=3^TD Vaccine
 ;;^UTILITY(U,$J,358.3,24406,0)
 ;;=90656^^120^1218^4^^^^1
 ;;^UTILITY(U,$J,358.3,24406,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24406,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,24406,1,3,0)
 ;;=3^Flu Vaccine,Preservative-Free
 ;;^UTILITY(U,$J,358.3,24407,0)
 ;;=90661^^120^1218^3^^^^1
 ;;^UTILITY(U,$J,358.3,24407,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24407,1,2,0)
 ;;=2^90661
 ;;^UTILITY(U,$J,358.3,24407,1,3,0)
 ;;=3^Flu Vaccine,Lo Dose Syr (Flucelvax)
 ;;^UTILITY(U,$J,358.3,24408,0)
 ;;=90662^^120^1218^1^^^^1
 ;;^UTILITY(U,$J,358.3,24408,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24408,1,2,0)
 ;;=2^90662
 ;;^UTILITY(U,$J,358.3,24408,1,3,0)
 ;;=3^Flu Vaccine,High Dose Syr (Fluzone)
 ;;^UTILITY(U,$J,358.3,24409,0)
 ;;=S9445^^120^1219^3^^^^1
 ;;^UTILITY(U,$J,358.3,24409,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24409,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,24409,1,3,0)
 ;;=3^Pt Education,NOC Individual
 ;;^UTILITY(U,$J,358.3,24410,0)
 ;;=99401^^120^1219^1^^^^1
 ;;^UTILITY(U,$J,358.3,24410,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24410,1,2,0)
 ;;=2^99401
 ;;^UTILITY(U,$J,358.3,24410,1,3,0)
 ;;=3^Preventive Counseling,Ind,15Min
 ;;^UTILITY(U,$J,358.3,24411,0)
 ;;=99402^^120^1219^2^^^^1
 ;;^UTILITY(U,$J,358.3,24411,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24411,1,2,0)
 ;;=2^99402
 ;;^UTILITY(U,$J,358.3,24411,1,3,0)
 ;;=3^Preventive Counseling,Ind,30Min
 ;;^UTILITY(U,$J,358.3,24412,0)
 ;;=99354^^120^1220^1^^^^1
 ;;^UTILITY(U,$J,358.3,24412,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24412,1,2,0)
 ;;=2^99354
 ;;^UTILITY(U,$J,358.3,24412,1,3,0)
 ;;=3^Prolonged Svc w/ Pt,1st Hr
 ;;^UTILITY(U,$J,358.3,24413,0)
 ;;=99355^^120^1220^2^^^^1
 ;;^UTILITY(U,$J,358.3,24413,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24413,1,2,0)
 ;;=2^99355
 ;;^UTILITY(U,$J,358.3,24413,1,3,0)
 ;;=3^Prolonged Svc w/ Pt,Ea Addl 30Min
 ;;^UTILITY(U,$J,358.3,24414,0)
 ;;=99358^^120^1220^3^^^^1
 ;;^UTILITY(U,$J,358.3,24414,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24414,1,2,0)
 ;;=2^99358
 ;;^UTILITY(U,$J,358.3,24414,1,3,0)
 ;;=3^Prolonged Svc w/o Pt,1st Hr
 ;;^UTILITY(U,$J,358.3,24415,0)
 ;;=99359^^120^1220^4^^^^1
 ;;^UTILITY(U,$J,358.3,24415,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24415,1,2,0)
 ;;=2^99359
 ;;^UTILITY(U,$J,358.3,24415,1,3,0)
 ;;=3^Prolonged Svc w/o Pt,Ea Addl 30Min
 ;;^UTILITY(U,$J,358.3,24416,0)
 ;;=J85.2^^121^1221^8
 ;;^UTILITY(U,$J,358.3,24416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24416,1,3,0)
 ;;=3^Abscess, lung without pneumonia
 ;;^UTILITY(U,$J,358.3,24416,1,4,0)
 ;;=4^J85.2
 ;;^UTILITY(U,$J,358.3,24416,2)
 ;;=^5008307
 ;;^UTILITY(U,$J,358.3,24417,0)
 ;;=K75.0^^121^1221^7
 ;;^UTILITY(U,$J,358.3,24417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24417,1,3,0)
 ;;=3^Abscess, liver
 ;;^UTILITY(U,$J,358.3,24417,1,4,0)
 ;;=4^K75.0
 ;;^UTILITY(U,$J,358.3,24417,2)
 ;;=^5008824
 ;;^UTILITY(U,$J,358.3,24418,0)
 ;;=K61.1^^121^1221^10
